Delivery Order SPE2DB20D2104-SPE2DB25FMXFT
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,272.44 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Crexont ER 70 mg-280 mg capsules (120-count). This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $6,672.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on September 5, 2025, with completion targeted for September 8, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,342.98 to AmerisourceBergen Drug Corp for the supply of Crexont ER 70 mg-280 mg capsules (120 count) on July 21, 2025, with ultimate completion scheduled for July 22, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for CREXONT ER 70 mg–280 mg capsules (120-count packaging) with a ceiling value of $3,237.83. This firm fixed-price delivery order is non-competitive, representing one of numerous pharmaceutical supply transactions executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,989.09 to AmerisourceBergen Drug Corp for Crexont ER (87.5 mg-350 mg capsules, 120 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a competitive award under DLA's existing pharmaceutical supply contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CREXONT ER 52.5 MG-210 MG capsules (120-count) on May 20, 2025, with a ceiling value of $2,394.89 and firm fixed pricing. This competitive award, which carries no set-aside designation, is classified as a child contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement transaction under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,192.05 to AmerisourceBergen Drug Corp for CREXONT ER 87.5 mg-350 mg capsules (120-count supply). This is a firm fixed-price delivery order with no set-aside designation, completed on September 3, 2025, and performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its...
- This federal contract award, valued at $2,917.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. The contract covers the delivery of 4567058765 ! CREXONT ER 52.5 MG-210 MG CAP 120S medical products, with a completion date of January 28, 2025. Amerisourcebergen holds a significant...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (100s) on September 5, 2025, with a ceiling value of $3,179.78 and an ultimate completion date of September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,158.96 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the drug product Creon DR. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...